Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 464,817 shares of the financial services provider's stock, valued at approximately $48,081,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.08% of Aflac as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Private Trust Co. NA boosted its position in Aflac by 1.3% during the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider's stock worth $791,000 after purchasing an additional 99 shares during the period. TKG Advisors LLC raised its stake in Aflac by 0.5% in the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider's stock valued at $2,230,000 after purchasing an additional 103 shares in the last quarter. Robertson Stephens Wealth Management LLC raised its stake in shares of Aflac by 1.6% during the fourth quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider's stock worth $720,000 after acquiring an additional 107 shares in the last quarter. Family Legacy Inc. raised its stake in shares of Aflac by 4.3% during the fourth quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider's stock worth $270,000 after acquiring an additional 107 shares in the last quarter. Finally, Quotient Wealth Partners LLC increased its stake in shares of Aflac by 4.3% in the fourth quarter. Quotient Wealth Partners LLC now owns 2,615 shares of the financial services provider's stock worth $270,000 after buying an additional 108 shares during the period. Institutional investors and hedge funds own 67.44% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on AFL shares. UBS Group boosted their target price on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a report on Wednesday, April 2nd. Piper Sandler upped their price target on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Barclays increased their price target on Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a report on Thursday, May 1st. Wall Street Zen lowered Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Finally, JPMorgan Chase & Co. increased their price target on Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, Aflac has an average rating of "Hold" and a consensus target price of $104.93.
Read Our Latest Report on Aflac
Insider Activity at Aflac
In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total value of $290,675.00. Following the transaction, the director now directly owns 6,728 shares in the company, valued at approximately $711,149.60. This trade represents a 29.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the transaction, the director now directly owns 70,992 shares in the company, valued at approximately $7,496,045.28. This trade represents a 34.26% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 71,552 shares of company stock valued at $7,609,382. Insiders own 0.80% of the company's stock.
Aflac Stock Up 0.7%
NYSE AFL traded up $0.68 on Friday, hitting $103.49. 3,415,441 shares of the stock traded hands, compared to its average volume of 2,112,682. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The stock has a 50-day moving average of $106.15 and a 200 day moving average of $106.15. The company has a market capitalization of $55.95 billion, a P/E ratio of 10.78, a price-to-earnings-growth ratio of 3.24 and a beta of 0.84. Aflac Incorporated has a twelve month low of $86.46 and a twelve month high of $115.50.
Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.67 by ($0.01). The firm had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. Aflac had a net margin of 28.76% and a return on equity of 16.20%. The firm's revenue for the quarter was down 37.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.66 earnings per share. As a group, analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.
Aflac Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 2nd. Investors of record on Wednesday, May 21st will be given a dividend of $0.58 per share. The ex-dividend date of this dividend is Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a yield of 2.24%. Aflac's payout ratio is 36.25%.
Aflac Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles

Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.